Health News (Reuters)

Ablynx soars after rejects Novo Nordisk's $3.1 billion biotech bid

COPENHAGEN/BRUSSELS (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin maker, went public with a 2.6 billion euro ($3.1 billion) bid for Belgian biotech group Ablynx on Monday, seeking a new source of growth by bolstering its treatments for rare blood disorders.

Sanofi and Regeneron boost investment in cancer drug cemiplimab

PARIS (Reuters) - France's Sanofi and U.S Regeneron said on Monday they would inject an additional $1 billion in the development of cemiplimab, an antibody that could, if successful, be used to treat a wide range of cancers.

German drugmaker Dermapharm plans March IPO - sources

FRANKFURT (Reuters) - German non-prescription drugmaker Dermapharm is planning to list on the Frankfurt stock exchange before the Easter holidays, in a deal that is expected to value the company at more than 1 billion euros ($1.2 billion), people familiar with the matter said.‎

Axovant shares plunge after key drug program scrapped

(Reuters) - Axovant Sciences Ltd's shares fell nearly 50 percent on Monday after the company scrapped its intepirdine program following the failure of its lead experimental treatment in a mid-stage study on patients suffering from a type of dementia.

Novo Nordisk's $3.1 billion Ablynx bid rejected by Belgian biotech

COPENHAGEN/BRUSSELS (Reuters) - Denmark's Novo Nordisk, the world's biggest maker of insulin, went public with a 2.6 billion euro ($3.1 billion) bid for Belgian biotech group Ablynx on Monday as it seeks to bolster its treatments for rare blood disorders.

Death toll in South Africa listeria outbreak jumps to 61

JOHANNESBURG (Reuters) - The death toll from an outbreak of listeria in South Africa has jumped beyond 60 in the past month, health authorities said on Monday, adding they had closed a poultry abattoir where the bug that causes the disease had been detected.

Regeneron forms consortium to accelerate gene sequencing project

(Reuters) - Regeneron Pharmaceuticals Inc on Monday announced a collaboration with rival drugmakers that will speed its effort to collect genetic information on 500,000 people in the UK Biobank database, a project it believes could help accelerate new drug discovery and improve approval success rates.

Zambia declares curfew in Lusaka slum struck by cholera

LUSAKA (Reuters) - Zambia has declared a curfew in a poor Lusaka township badly affected by a cholera outbreak that has killed 58 people across the country since September, the government said on Sunday.

ADHD drug tied to heart defects in babies

(Reuters Health) - - Pregnant women who take drugs like Ritalin and Concerta for attention deficit hyperactivity disorder (ADHD) are more likely than those who don’t to have babies with heart deformities and other birth defects, a recent study suggests.

Pages